Structure-based in silico design of a high-affinity dipeptide inhibitor for novel protein drug target Shikimate kinase of Mycobacterium tuberculosis

Chemical Biology & Drug Design
Manoj KumarPunit Kaur

Abstract

Tuberculosis remains one of the most dreaded infectious diseases notwithstanding the availability of a number of anti-tuberculosis drugs. The recent rise of multidrug-resistant tuberculosis and its association with HIV infection poses a challenging health concern. Therefore, there exists a pressing requirement to identify novel drug targets and develop new anti-tuberculosis drugs that will be effective against multidrug-resistant-tuberculosis. Shikimate kinase is a novel and attractive drug target as it is vital for the survival of Mycobacterium tuberculosis but is absent in mammals. Hence, inhibitors designed against shikimate kinase will be specific to the pathogen and be least harmful to the host. Till date, no drug candidates are available against this target. The crystal structure of Mycobacterium tuberculosis shikimate kinase complexed with shikimate has been used to identify a dipeptide inhibitor using in silico structure-based design approach. The designed peptidic inhibitor has a predicted binding affinity of 5.5 nm which is 8000 times better than substrate shikimate and 10 times greater than the best suggested inhibitor. It is potent in both the known open and closed LID conformations of target protein. As small pepti...Continue Reading

References

Jan 1, 1988·Annual Review of Biochemistry·G M Kishore, D M Shah
Feb 1, 1994·Antimicrobial Agents and Chemotherapy·G M DaviesR G Wilson
Mar 29, 2001·Journal of Pharmacological and Toxicological Methods·C A Lipinski
Dec 14, 2002·Journal of Molecular Graphics & Modelling·C M VenkatachalamM Waldman
Jan 8, 2003·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Jean B Nachega, Richard E Chaisson
May 30, 2003·Journal of Medicinal Chemistry·Renxiao WangShaomeng Wang
Mar 12, 2004·Annual Review of Plant Physiology and Plant Molecular Biology·Klaus M. Herrmann, Lisa M. Weaver
Dec 8, 2004·Acta Crystallographica. Section D, Biological Crystallography·José Henrique PereiraWalter Filgueira de Azevedo
Oct 6, 2006·Journal of Molecular Biology·Marcus D HartmannHans D Bartunik
Feb 16, 2007·The New England Journal of Medicine·Mario C Raviglione, Ian M Smith
May 20, 2008·Bioorganic & Medicinal Chemistry Letters·Aldo Segura-Cabrera, Mario A Rodríguez-Pérez
Jun 17, 2008·Chemical Biology & Drug Design·Vincent M Rotello

❮ Previous
Next ❯

Citations

May 20, 2011·Journal of Molecular Modeling·Carolina Pasa Vianna, Walter F de Azevedo

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antitubercular Agents (ASM)

Antitubercular agents are pharmacologic agents for treatment of tuberculosis. Discover the latest research on antitubercular agents here.

Antitubercular Agents

Antitubercular agents are pharmacologic agents for treatment of tuberculosis. Discover the latest research on antitubercular agents here.